Kearns-Sayre SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Kearns-Sayre Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Office
Amy Goldstein is a Pediatric Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Goldstein is rated as an Elite provider by MediFind in the treatment of Kearns-Sayre Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Kearns-Sayre Syndrome, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Mitochondrial Trifunctional Protein Deficiency, Hirsutism in Women, and Gastrostomy. Dr. Goldstein is board certified in American Board Of Psychiatry And Neurology - Psychiatry.
Marek Niedziela practices practicing medicine in Poznan, Poland. Mr. Niedziela is rated as an Elite expert by MediFind in the treatment of Kearns-Sayre Syndrome. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Kearns-Sayre Syndrome, Intersex, Progressive External Ophthalmoplegia, Hormone Replacement Therapy (HRT), and Thyroidectomy.
Advocate Medical Group Primary Care
Cherie Hawkins is a primary care provider, practicing in Family Medicine in Chicago, Illinois. Dr. Hawkins is rated as an Experienced provider by MediFind in the treatment of Kearns-Sayre Syndrome. Her clinical expertise encompasses Diabetic Hyperglycemic Hyperosmolar Syndrome, Kearns-Sayre Syndrome, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Hawkins is board certified in American Osteopathic Board Of Family Physicians, Family Practice.
Summary: The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Summary: Mitochondrial diseases are a genetically diverse group of disorders, some of which are caused by mutations or deletions in the mitochondrial DNA (mtDNA) and which display a wide range of severity and phenotypes. Despite a prevalence of roughly 1 in 8500 in the population there is no effective treatments for the majority of mitochondrial diseases beyond supportive care (Gorman 2016, Elliott 2008). ...